![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Theraclone doses first patient in Phase 1 TCN-032 drug trial
Theraclone Sciences has dosed first patient in a randomized, double-blind, dose-escalation Phase 1 trial...
FDA approves Amphastar Enoxaparin Sodium Injection
The US Food and Drug Administration has approved Amphastar Pharmaceuticals' abbreviated new drug application...
Dey Pharma to provide EpiPen Auto-Injectors
Mylan's subsidiary Dey Pharma is set to offer EpiPen 2-Pak and EpiPen Jr 2-Pak (epinephrine)...
Unilife develops safety syringe to reconstitute lyophilized drugs
Unilife has developed Unifill EZMix multiple-chamber ready-to-fill (prefilled) safety syringe for lyophilized drugs and vaccines...
Allos recruits first patient in Phase 3 PTCL drug trial
Allos Therapeutics has recruited first patient in a Phase 3 multi-center, randomized, open-label (PDX-017) Phase...
Abbott two new strengths of CPP drug gets FDA nod
Abbott has received the US Food and Drug Administration (FDA) approval for two new strengths...
AVI BioPharma starts patient dosing in DMG drug Phase 2 trial
AVI BioPharma has started patient dosing in a placebo-controlled Phase 2 trial to evaluate eteplirsen...
Biogen Idec, Abbott release Select Phase 2b RRMS drug trial results
Biogen Idec and Abbott have released top-line results from a double-blind, dose-ranging, randomized and placebo-controlled...
Innovacyn introduces eye, ear formulations
Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash...
Glenmark settles patent case with Daiichi, Genzyme
Glenmark Pharmaceuticals has settled patent litigation suit with Daiichi Sankyo and Genzyme in relation to...